高通量筛选（High-Throughput Screening，HTS）技术在多个领域有广泛的应用，以下是一些主要的应用场景：1. 药物发现：HTS技术被广泛应用于药物发现过程中，用于从大量化合物库中筛选出具有潜在生物活性的化合物，作为药物开发的先导化合物。2. 基因组学研究：在基因组水平上，HTS技术可以用于从头测序（de novo ...
高通量筛选(High throughput screening,HTS)HTS技术是指以分子水平和细胞水平的实验方法为基础,以微板形式作为实验工具载体,以自动化操作系统执
High-Throughput Screening (HTS) With ibidi µ-Plates | Large-Scale Live Cell Imaging Solutions | High-Throughput Wound Healing Assays | High Throughput Tube Formation Assays | Impedance-Based Wound Healing Assays Using ECIS
Accelerate and improve high-throughput screening (HTS). Learn how to achieve higher-quality leads in less time with the Tetra Scientific Data and AI Cloud.
So let’s break it down. What is a primary cell screen and what is High-Throughput Screening (HTS)? As I’ll explain shortly, a primary cell screen is just a high-throughput screen using primary cells. HTS is a method used in drug discovery and the development of therapeutic agents whic...
High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target, for example through binding assays. High-throughput screening methods are extensively used in the pharmaceutical industry, ...
This chapter describes a high-throughput screening campaign used to identify inhibitors of SSB-protein interactions. A screen targeting the PriA-SSB interface from Klebsiella pneumoniae is presented as an example, but the methods may be adapted to target nearly any SSB interaction....
高通量筛选(HTS)在分子水平和细胞水平的实验方法为基础,以微板形式作为实验工具载体,运用自动化的筛选系统在 短时间内、在特定的筛选模型上完成数以千计,甚至万计化合物样品的活性测试。一般而言,日筛选能力应在10000次以上方 可以称为高通量筛选。 技术优势 ...
High throughput screening (HTS) of diverse compound libraries is a highly significant source of hit compounds. Assay automation and technology advances continue to have a significant impact on the range, mode and disease relevance of HTS campaigns. HTS assay is just the beginning of the hit findin...
The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029. Report Includes